Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CVM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CVM

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield 0.21 %
Consecutive Years 0
Forward Annual Dividend 0.0083 USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 28.08.1996

CEL-SCI Corp

CVM
Current price
3.96 USD -0.14 USD (-3.41%)
Last closed 4.17 USD
ISIN US1508377066
Sector Healthcare
Industry Biotechnology
Exchange NYSE
Capitalization 21 072 506 USD
Yield for 12 month +180.85 %
1Y
3Y
5Y
10Y
15Y
CVM
21.11.2021 - 28.11.2021

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia. Address: 8229 Boone Boulevard, Vienna, VA, United States, 22182

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

240.02 USD

P/E Ratio

Dividend Yield

Financials CVM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CVM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-3 969 183 USD

Last Year

-3 958 334 USD

Current Quarter

Last Quarter

-991 580 USD
EBITDA -23 937 078 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -62.86 %
PEG Ratio
Return On Equity TTM -244.56 %
Wall Street Target Price 240.02 USD
Revenue TTM 28 558 USD
Book Value 2.85 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -62.70 %
Dividend Yield
Gross Profit TTM -17 624 736 USD
Earnings per share -12.30 USD
Diluted Eps TTM -12.30 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation CVM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 11 797.42
Enterprise Value EBITDA -3.71
Price Book MRQ 2.68

Technical Indicators CVM

For 52 Weeks

1.98 USD 66.60 USD
50 Day MA 3.86 USD
Shares Short Prior Month 251 218
200 Day MA 13.19 USD
Short Ratio 0.83
Shares Short 269 275
Short Percent 8.76 %